Novartis Settles Lawsuit with Henrietta Lacks' Family Over Unauthorized Use of HeLa Cells

Pharmaceutical company Novartis has reached a confidential settlement with the family of Henrietta Lacks, a Black woman whose cells were taken without consent in 1951 during her treatment for cervical cancer at Johns Hopkins Hospital. The lawsuit, filed in August 2024, accused Novartis of profiting from the HeLa cell line, which has been pivotal in medical research and the development of vaccines, including those for polio and COVID-19. This settlement marks the second legal resolution involving Lacks' descendants and a major biotech firm, following a previous agreement with Thermo Fisher Scientific in 2023.

BenzingaNovartis Settles Lawsuit With Estate of Henrietta LacksNew York Times

Henrietta Lacks, who died at the age of 31, had her cells removed without her knowledge during cancer treatment. These cells, known as HeLa cells, became the first immortal human cell line, capable of dividing indefinitely in laboratory conditions. Since their discovery, HeLa cells have been cited in over 110,000 scientific publications and have contributed to significant advancements in medical research, including cancer studies and vaccine development.

New York TimesHeLa Justice: Family of Henrietta Lacks Reaches Second Settlement Over ‘Stolen’ CellsNovartis Settles Lawsuit With Estate of Henrietta Lacks

The Lacks family has long sought accountability from companies that have profited from the use of HeLa cells without consent. The recent settlement with Novartis is part of a broader movement addressing medical ethics and racial injustices in healthcare. Civil rights attorney Ben Crump, representing the Lacks family, emphasized that this agreement signifies a step toward justice and recognition of Lacks' legacy. He stated, “For the family and her grandchildren, this is certainly justice,” highlighting the importance of restoring dignity to Lacks’ story.

HeLa Justice: Family of Henrietta Lacks Reaches Second Settlement Over ‘Stolen’ Cells

In a joint statement, both Novartis and the Lacks family expressed satisfaction with the resolution of the lawsuit, although they did not disclose the financial terms of the settlement. The statement acknowledged the historical context of Lacks' contributions to science and the ethical considerations surrounding her case.

Novartis Settles Lawsuit With Estate of Henrietta Lacks

Despite the settlement, critics argue that it does not fully address the systemic issues of racial exploitation in medical research. The Lacks estate has previously highlighted the broader implications of using biological materials obtained without consent, calling for more comprehensive reforms in medical ethics and patient rights.

Novartis Settles Lawsuit With Estate of Henrietta Lacks

• “For the family and her grandchildren, this is certainly justice,” — Ben Crump, Civil Rights Attorney

HeLa Justice: Family of Henrietta Lacks Reaches Second Settlement Over ‘Stolen’ Cells

• “the story of Henrietta Lacks, whose cervical cancer cells were surreptitiously commercialized for research purposes without her knowledge.” — Novartis Statement

New York Times

The Lacks family continues to pursue legal actions against other pharmaceutical companies that have utilized HeLa cells without consent. This ongoing fight underscores the need for greater accountability and reform in medical research practices, particularly regarding informed consent and the rights of marginalized individuals in healthcare.

HeLa Justice: Family of Henrietta Lacks Reaches Second Settlement Over ‘Stolen’ Cells